|
|
Age |
Traits |
Female |
Male |
|
|
9 weeks |
*PCV (%) |
41.50 ± 0.65a |
39.75 ± 1.03b |
|
|
|
*WBC (×103/µl) |
24.55 ± 1.09a |
21.00 ± 1.50b |
|
|
|
*NEU (%) |
43.00 ± 3.03a |
39.76 ± 5.59b |
|
|
|
*LYM (%) |
56.00 ± 3.24b |
58.25 ± 5.30a |
|
|
|
*EOS (%) |
0.05 ± 0.50b |
1.50 ± 0.79a |
| MON (%) |
0.50 ± 0.50 |
0.50 ± 0.50 |
|
|
|
|
17 weeks |
|
|
|
|
|
|
PCV (%) |
42.00 ± 1.08 |
41.25 ± 2.66 |
|
|
|
*WBC (×103/µl) |
30.88 ± 1.81b |
35.90 ± 2.54a |
|
|
|
*NEU (%) |
39.50 ± 5.62b |
44.25 ± 5.27a |
| LYM (%) |
53.25 ± 6.97 |
53.00 ± 5.00 |
|
|
|
|
|
*EOS (%) |
4.25 ± 1.32a |
1.25 ± 0.75b |
| MON (%) |
3.00 ± 1.73 |
1.50 ± 0.96 |
|
|
|
|
25 weeks |
|
|
|
| PCV (%) |
44.00 ± 0.41 |
43.75 ± 1.03 |
|
|
|
|
|
WBC (×103/µl) |
37.43 ± 2.96 |
37.98 ± 1.10 |
|
|
|
*NEU (%) |
28.75 ± 2.14b |
37.00 ± 3.98a |
|
|
|
*LYM (%) |
66.00 ± 1.58a |
54.75 ± 3.18b |
| EOS (%) |
2.30 ± 1.32 |
3.50 ± 1.50 |
|
|
| MON (%) |
3.75 ± 0.75 |
4.75 ± 0.75 |
|
|